February 2, 2026: Gastroparesis is Most Common Injury in Lawsuits Against Ozempic and Other GLP-1 Drugs According to court documents, gastroparesis is the most frequently listed injury in complaints filed as part of the GLP-1 product liability litigation (MDL -3094), which includes Ozempic claims
Eat a lot of different vegetables and healthy proteins as the foundation of your diet
Unlocking Longevity with DSIP Epithalon Peptide Stack This blog highlights how the DSIP peptide enhances sleep quality, reduces stress, and supports neurotransmitter balance, while Epithalon promotes anti-aging by stimulating telomerase activity to protect cellular DNA
Expel all air bubbles from the syringe to ensure your measurement is accurate
Quantitative analysis of autophagic flux by confocal pH-imaging of autophagic intermediates
Companies are investing in advanced production technologies, particularly for injectable therapeutics, including GLP-1 products